Societal CDMO competitors and similar companiesClear all
Amicus Therapeutics's competitors and similar companies include BTG, Zogenix and Array BioPharma.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | ||
Founding Date | Founding Date 2002 | Founding Date 1948 | Founding Date 2006 | Founding Date 1998 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Emeryville, US HQ Maidenhead, GB | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | |
Employees | Employees 58415% increase | Employees 5284% increase | Employees 14157% increase | Employees 29843% increase |
Valuation ($) | Valuation ($) 3.2 b | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) N/A |
Twitter followers | Twitter followers 2.1 k | Twitter followers 1.1 k | Twitter followers 2 | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 9 | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 2.3 | Average likes per tweet (last 30 days) 4.5 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 2.9 | Employee Rating 3.2 | Employee Rating 2.7 | Employee Rating 3.5 |
Financial | ||||
Revenue (est.) | Revenue (est.) $329.2m (FY, 2022) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods $38.6m (FY, 2022) | Cost of goods £221m (FY, 2019) | Cost of goods $4.8m (FY, 2021) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit $290.6m (FY, 2022) | Gross profit £510.3m (FY, 2019) | Gross profit N/A | Gross profit $114.4m (FY, 2018) |
Net income | Net income ($236.6m) (FY, 2022) | Net income £88.3m (FY, 2019) | Net income ($227.4m) (FY, 2021) | Net income ($147.7m) (FY, 2018) |
For sources of this data, please see the company profile
View company profiles
Zogenix
HQ
Emeryville, US
Employees
141
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyArray BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company